制药企业社会责任信息披露的影响因素探究

Research on the influencing factors of social responsibility information disclosure in pharmaceutical enterprises

探究A股上市的66家制药公司的企业社会责任信息披露的影响因素。从公司治理的视角出发,基于代理理论、资源依赖理论及信号理论,从董事会领导结构、独立董事比例、董事会性别构成、董事会监管力度、股权集中度和薪酬激励等方面选取了6个前因变量,以企业社会责任信息披露质量作为结果变量,用fsQCA进行分析。找到引发高企业社会责任信息披露质量的3种路径:股权激励型、外部监管型和决策高效型;同时发现引起低企业社会责任信息披露质量的4种路径:协调失衡型、内控失效型、监管缺失型和高度集权型。结果表明:董事会领导结构是影响企业社会责任信息披露的核心因素,适度调整董事会构成和合理的股权激励有利于信息披露质量提升。

To explore the influencing factors of corporate social responsibility information disclosure in 66 pharmaceutical companies listed in A shares. From the perspective of corporate governance, based on agency theory, resource dependence theory and signal theory, six pre-dependent variables were selected in the aspects of board leadership structure, proportion of independent directors, gender composition of board, supervision of board, ownership concentration and salary incentive, and the quality of corporate social responsibility information disclosure was taken as the result variable and analyzed by fsQCA. Three types of enterprises with high quality of corporate social responsibility information disclosure were found: equity incentive, external supervision and decision-making. At the same time, four types of enterprises with low quality of corporate social responsibility information disclosure are found: coordination imbalance, internal control failure, lack of supervision and high centralization. The leadership structure of the board of directors is the core factor affecting the disclosure of corporate social responsibility information.